SINGULARITY FUTURE TECHNOLOG (SGLY)

US82935V3078 - Common Stock

1.55  -0.03 (-1.9%)

Fundamental Rating

2

Taking everything into account, SGLY scores 2 out of 10 in our fundamental rating. SGLY was compared to 7 industry peers in the Transportation Infrastructure industry. The financial health of SGLY is average, but there are quite some concerns on its profitability. SGLY is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

SGLY had negative earnings in the past year.
SGLY had a negative operating cash flow in the past year.
In the past 5 years SGLY always reported negative net income.
In the past 5 years SGLY reported 4 times negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -19.98%, SGLY is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -25.32%, SGLY is doing worse than 71.43% of the companies in the same industry.
Industry RankSector Rank
ROA -19.98%
ROE -25.32%
ROIC N/A
ROA(3y)-63.46%
ROA(5y)-99.95%
ROE(3y)-105.42%
ROE(5y)-120.84%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

SGLY does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

SGLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SGLY has more shares outstanding
SGLY has more shares outstanding than it did 5 years ago.
SGLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

SGLY has an Altman-Z score of -5.85. This is a bad value and indicates that SGLY is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SGLY (-5.85) is worse than 85.71% of its industry peers.
SGLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.85
ROIC/WACCN/A
WACC9.69%

2.3 Liquidity

SGLY has a Current Ratio of 2.77. This indicates that SGLY is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.77, SGLY is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
SGLY has a Quick Ratio of 2.77. This indicates that SGLY is financially healthy and has no problem in meeting its short term obligations.
SGLY has a better Quick ratio (2.77) than 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 2.77
Quick Ratio 2.77

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 86.54% over the past year.
The Revenue for SGLY has decreased by -34.92% in the past year. This is quite bad
SGLY shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -40.42% yearly.
EPS 1Y (TTM)86.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.88%
Revenue 1Y (TTM)-34.92%
Revenue growth 3Y-15.24%
Revenue growth 5Y-40.42%
Sales Q2Q%-44.04%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SGLY. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SGLY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SINGULARITY FUTURE TECHNOLOG

NASDAQ:SGLY (12/20/2024, 8:00:01 PM)

1.55

-0.03 (-1.9%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryTransportation Infrastructure
Earnings (Last)11-11 2024-11-11/amc
Earnings (Next)02-12 2025-02-12
Inst Owners0.65%
Inst Owner Change81.23%
Ins OwnersN/A
Ins Owner Change0%
Market Cap5.42M
Analysts82.86
Price TargetN/A
Short Float %0.69%
Short Ratio0.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.98
P/FCF N/A
P/OCF N/A
P/B 0.36
P/tB 0.36
EV/EBITDA N/A
EPS(TTM)-1.44
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.69
FCFYN/A
OCF(TTM)-0.69
OCFYN/A
SpS0.78
BVpS4.27
TBVpS4.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.98%
ROE -25.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-63.46%
ROA(5y)-99.95%
ROE(3y)-105.42%
ROE(5y)-120.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.77
Quick Ratio 2.77
Altman-Z -5.85
F-Score4
WACC9.69%
ROIC/WACCN/A
Cap/Depr(3y)62%
Cap/Depr(5y)107.33%
Cap/Sales(3y)7.58%
Cap/Sales(5y)10.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.88%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-34.92%
Revenue growth 3Y-15.24%
Revenue growth 5Y-40.42%
Sales Q2Q%-44.04%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y66.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-197.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-183.78%
OCF growth 3YN/A
OCF growth 5YN/A